Amerise Biosciences Intrinsic Value
Amerise Biosciences intrinsic value. Amerise Biosciences (AMERISE) median intrinsic value is ₹2.03 from 1 valuation models (range ₹2–₹2), vs current price ₹0.81 — +150.6% upside (Trading Below Calculated Value), margin of safety 60.1%. For current market price and key ratios, visit AMERISE stock price BSE.
AMERISE Valuation Methods Summary — DCF, Graham Number & P/E
Amerise Biosciences intrinsic value across 1 models vs current price ₹0.81 — upside/downside and value range per method. Read AMERISE ex-dividend dates for the complete payout history and dividend yield track record.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹2.03 | ₹1.83 - ₹2.23 | +150.6% | Book Value/Share: ₹7.14, P/B: 1.0x |
AMERISE Intrinsic Value vs Market Price — All Valuation Models
Amerise Biosciences fair value range ₹2–₹2 vs current market price ₹0.81 across 1 valuation models. Compare with Amerise Biosciences valuation methods to assess whether the stock is under or overvalued.
AMERISE Intrinsic Value Analysis — Undervalued or Overvalued?
Amerise Biosciences median intrinsic value ₹2.03, current price ₹0.81 — Trading Below Calculated Value by 150.6%, margin of safety 60.1%.
What is the intrinsic value of AMERISE?
Based on our comprehensive analysis using 1 different valuation methods, the estimated intrinsic value of Amerise Biosciences (AMERISE) is ₹2.03 (median value). With the current market price of ₹0.81, this represents a +150.6% variance from our estimated fair value.
The valuation range spans from ₹2.03 to ₹2.03, indicating ₹2.03 - ₹2.03.
Is AMERISE undervalued or overvalued?
Based on our multi-method analysis, Amerise Biosciences (AMERISE) appears to be trading below calculated value by approximately 150.6%.
AMERISE Cash Flow Quality — Operating & Free Cash Flow
Amerise Biosciences operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹-1 Cr | ₹-1 Cr | Negative Cash Flow | 3/10 |
| March 2025 | ₹3 Cr | ₹2 Cr | Positive Free Cash Flow | 7/10 |
| March 2024 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |